By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Neuphoria Therapeutics Inc.

Neuphoria Therapeutics Inc. (NEUP)

NASDAQ Market Data in USD, Fundamentals in AUD
$13.99
+$0.07
+0.50%
Last Update: 11 Sept 2025, 20:00
$26.30M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$2.12 - $15.14
52 Week Range

NEUP Stock Price Chart

Explore Neuphoria Therapeutics Inc. interactive price chart. Choose custom timeframes to analyze NEUP price movements and trends.

NEUP Company Profile

Discover essential business fundamentals and corporate details for Neuphoria Therapeutics Inc. (NEUP) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Pharmaceuticals

IPO Date

16 Dec 2021

Employees

8.00

CEO

Spyridon Papapetropoulos

Description

Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.

NEUP Financial Timeline

Browse a chronological timeline of Neuphoria Therapeutics Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 29 Sept 2025

EPS estimate is -$1.26.

Earnings released on 20 May 2025

EPS came in at $6.55 surpassing the estimated -$0.47 by +1.49K%, while revenue for the quarter reached $15.00M , beating expectations by +5.58K%.

Earnings released on 14 Feb 2025

EPS came in at -$1.23 surpassing the estimated -$2.01 by +38.81%, while revenue for the quarter reached $662.72K , beating expectations by +150.74%.

Stock split effective on 24 Dec 2024

Shares were split 1 : 12 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 30 Sept 2024

EPS came in at -$0.00 .

Earnings released on 31 Mar 2024

EPS came in at -$0.02 , while revenue for the quarter reached -$79.00K .

Earnings released on 31 Dec 2023

EPS came in at -$0.03 .

Earnings released on 30 Sept 2023

EPS came in at -$0.04 surpassing the estimated -$13.44 by +99.67%, while revenue for the quarter reached $5.48M , beating expectations by +74.48%.

Earnings released on 23 Feb 2023

EPS came in at -$17.65 falling short of the estimated -$15.30 by -15.30%, while revenue for the quarter reached $214.74K , missing expectations by -92.59%.

Earnings released on 25 Aug 2022

EPS came in at -$13.84 surpassing the estimated -$15.35 by +9.84%, while revenue for the quarter reached $29.75K , beating expectations by +108.54%.

Earnings released on 23 Feb 2022

EPS came in at -$20.33 falling short of the estimated -$8.76 by -132.12%.

Earnings released on 25 Aug 2021

NEUP Stock Performance

Access detailed NEUP performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run